AstraZeneca’s High Brilinta Price Leaves Analysts Wary
AstraZeneca (AZ) is pricing its recently approved blood-thinner Brilinta higher than Plavix, despite a required boxed warning the competing drug doesn’t have — a move that leaves analysts wary.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.